HDAC3 and triple-negative breast carcinoma: Remarkably, the JNK kinase (a typical MAPK family member)-dependent phosphorylation of HDAC3 is associated with a five times upregulation of its enzyme activity and three to 16 times increase in HDAC inhibitor selectivity for HDAC3 in triple-negative breast cancer cells, as compared to luminal subtypes.